WHO ICTRP trial
Anti-human globulin Rh D drug from effectiveness from review after vaccination…
RBR-27sdv5 · Registro Brasileiro de Ensaios Clinicos (ReBEC) · Recruiting
Key facts
| Trial ID | RBR-27sdv5 |
|---|---|
| Public title | Anti-human globulin Rh D drug from effectiveness from review after vaccination in women with postpartum negative factor blood and with complications risk in newborns |
| Scientific title | Evaluation of clinical efficacy of Kamrho-D® drug (anti-human globulin Rh D - Panamerican) in postpartum women Rh negative immunization, coombs indirect negative and sensitization risk |
| Primary sponsor | Hospital São Lucas da PUC/RS (Centro Coordenador) |
| Secondary sponsors | LAL Clinica Pesquisa e Desenvolvimento Ltda. |
| Registry | Registro Brasileiro de Ensaios Clinicos (ReBEC) |
| Recruitment status | Recruiting |
| Study type | Intervention |
| Phase | 3 |
| Countries | Brazil |
| Conditions | postpartum women with blood type negative Rh and indirect coombs test negative, whose newborn is positive Rh;D12.776.124.486.485.114.619.393.700 |
| Interventions | Study multicenter, prospective and non-comparative. They will be selected 232 female participants, puerperae with a negative Rh factor. The participants will receive a single dose of the drug (anti-Rh D human immunoglobulin), administered… |
| Registration date | Feb 3, 2016 |
| Registry page | ensaiosclinicos.gov.br |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: